Clozapine in the Elderly and Those with Medical Comorbidity, and Care Transitions-Lecture Presentation

Video Transcription

Video Summary

In the video, Dr. Jonathan Meyer discusses the use of Clozapine in elderly patients and those with medical comorbidity. He emphasizes that elderly patients with treatment-resistant schizophrenia can be safely started on Clozapine, and outlines strategies for treating those at higher risk for adverse events. He also discusses the use of Clozapine in those with metabolic or seizure disorders, and the risks and benefits of re-challenging patients who have previously discontinued Clozapine. Dr. Meyer emphasizes the importance of thorough communication and management of unique Clozapine-related treatment issues to increase acceptance and success as patients transition across care settings. He also discusses the use of point-of-care devices for monitoring neutrophil counts and offers recommendations for managing side effects such as constipation and orthostasis. Overall, the video provides insights and recommendations for safely and effectively using Clozapine in elderly patients and those with medical comorbidity.

Keywords

Clozapine

elderly patients

medical comorbidity

treatment-resistant schizophrenia

adverse events

metabolic disorders

seizure disorders

communication